6-methyl-2-ethyl-3-hydroxypyridine has been researched along with Chronic Disease in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Konoplya, AI; Laskov, VB; Shul'ginova, AA | 1 |
| Dolgushina, AI | 1 |
| Kazeko, NI; Oskolkov, SA; Zhmurov, VA | 1 |
| Akberova, SI; Sologub, AA; Ziangirova, GG | 1 |
| Rudyk, BI; Sabadyshin, RA | 1 |
1 trial(s) available for 6-methyl-2-ethyl-3-hydroxypyridine and Chronic Disease
| Article | Year |
|---|---|
[Efficacy of emoxipine and mexidol in patients with chronic disorders of the digestive system and atherosclerosis of the abdominal aorta].
Topics: Abdominal Pain; Aged; Antioxidants; Aorta, Abdominal; Atherosclerosis; Chronic Disease; Digestive System Diseases; Female; Humans; Infusions, Intravenous; Lipid Peroxidation; Lipid Peroxides; Male; Picolines; Single-Blind Method; Treatment Outcome | 2011 |
4 other study(ies) available for 6-methyl-2-ethyl-3-hydroxypyridine and Chronic Disease
| Article | Year |
|---|---|
[Immune and oxygen disturbances in patients with chronic cerebral ischemia and their correction].
Topics: Adult; Amino Acids; Antioxidants; Brain Ischemia; C-Reactive Protein; Chronic Disease; Complement C1 Inhibitor Protein; Complement Factor H; Complement System Proteins; Cytokines; Drug Therapy, Combination; Female; Heme; Humans; Hydrogen Peroxide; Immunoglobulins; Male; Malondialdehyde; Middle Aged; Nootropic Agents; Picolines; Piracetam | 2015 |
[Clinical and biochemical manifestations of chronic pyelonephritis and their correction in population of the northen areas of the Tyumen Territory].
Topics: Adolescent; Adult; Antioxidants; Biomarkers; Chronic Disease; Female; Humans; Male; Middle Aged; Picolines; Pyelonephritis; Siberia | 2004 |
[Emoxipin as an inhibitor of angiogenesis].
Topics: Animals; Antioxidants; Chick Embryo; Chronic Disease; Cornea; Depression, Chemical; Drug Evaluation, Preclinical; Fluorescein Angiography; Keratitis; Neovascularization, Pathologic; Picolines; Rabbits; Time Factors; Yolk Sac | 1992 |
[The significance of the antioxidant properties of emoxipin in the combined treatment of patients with chronic heart failure].
Topics: Adult; Aged; Antioxidants; Chronic Disease; Drug Evaluation; Drug Therapy, Combination; Female; Heart Failure; Humans; Lipid Peroxidation; Male; Middle Aged; Picolines | 1992 |